Berberine sensitizes rapamycin-mediated human hepatoma cell death in vitro

被引:30
作者
Guo, Na [1 ]
Yan, Aili [1 ]
Gao, Xingchun [1 ]
Chen, Yanke [2 ]
He, Xinying [1 ]
Hu, Zhifang [1 ]
Mi, Man [1 ]
Tang, Xu [3 ]
Gou, Xingchun [1 ]
机构
[1] Xian Med Univ, Inst Basic Med Sci, Lab Cell Biol & Translat Med, Xian 710021, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Cell Biol & Genet, Coll Med, Xian 710032, Shaanxi, Peoples R China
[3] Sichuan Coll Tradit Chinese Med, Dept Pathol, Mianyang 721000, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; rapamycin; mammalian target of rapamycin; cluster of differentiation 147; human hepatoma cell; APOPTOSIS; AUTOPHAGY;
D O I
10.3892/mmr.2014.2608
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Rapamycin is clinically used as an immunosuppressant. Increasing evidence suggests that rapamycin has an important inhibitory role in the development and progression of different types of cancer and that it is a promising candidate for cancer chemotherapy. Berberine is an isoquinoline alkaloid isolated from medicinal plant species, which has been used in traditional Chinese medicine with no significant side effects. Recent research has demonstrated that berberine has anticancer activity against various types of cancer, mediated through the suppression of mammalian target of rapamycin (mTOR). The present study aimed to investigate the in vitro synergistic anticancer effect of combined treatment of rapamycin at various concentrations (0, 10, 50, 100 and 200 nM) and berberine (62.5 mu M) in SMMC7721 and HepG2 hepatocellular carcinoma (HCC) cell lines, and the potential underlying molecular mechanism. The combined use of rapamycin and berberine was found to have a synergistic cytotoxic effect, with berberine observed to maintain the cyotoxic effect of rapamycin on HCC cells at a lower rapamycin concentration. Moreover, the cells treated with the combination of the two agents exhibited significantly decreased protein levels of phosphorylated (p)-p70S6 kinase 1 (Thr389), the downstream effector of mTOR, compared with the cells treated with rapamycin or berberine alone. Furthermore, overexpression of cluster of differentiation (CD) 147, a transmembrance glycoprotein associated with the anticancer effects of berberine, was found to upregulate p-mTOR expression and inhibit cell death in SMMC7721 cells co-treated with rapamycin and berberine. In conclUsion, the findings of the present study suggest that the combined use of rapamycin and berberine may improve HCC therapy through synergistically inhibiting the mTOR signaling pathway, which is at least in part, mediated through CD147.
引用
收藏
页码:3132 / 3138
页数:7
相关论文
共 20 条
[1]
Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4 [J].
Espert, Lucile ;
Denizot, Melanie ;
Grimaldi, Marina ;
Robert-Hebmann, Veronique ;
Gay, Bernard ;
Varbanov, Mihayl ;
Codogno, Patrice ;
Biard-Piechaczyk, Martine .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (08) :2161-2172
[2]
Targeting mTOR Pathways in Human Malignancies [J].
Fasolo, Angelica ;
Sessa, Cristiana .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (19) :2766-2777
[3]
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma [J].
Finn, Richard S. ;
Poon, Ronnie T. P. ;
Yau, Thomas ;
Klumpen, Heinz-Josef ;
Chen, Li-Tzong ;
Kang, Yoon-Koo ;
Kim, Tae-You ;
Gomez-Martin, Carlos ;
Rodriguez-Lope, Carlos ;
Kunz, Tiffany ;
Paquet, Thierry ;
Brandt, Ulrike ;
Sellami, Dalila ;
Bruix, Jordi .
JOURNAL OF HEPATOLOGY, 2013, 59 (06) :1271-1277
[4]
Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011
[5]
HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation [J].
Gou, Xingchun ;
Ru, Qiang ;
Zhang, Hongxin ;
Chen, Yanke ;
Li, Ling ;
Yang, Hushan ;
Xing, Jinliang ;
Chen, Zhinan .
CANCER SCIENCE, 2009, 100 (05) :837-843
[6]
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells [J].
Grabinski, Nicole ;
Ewald, Florian ;
Hofmann, Bianca T. ;
Staufer, Katharina ;
Schumacher, Udo ;
Nashan, Bjoern ;
Juecker, Manfred .
MOLECULAR CANCER, 2012, 11
[7]
Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147 [J].
Hou, Qian ;
Tang, Xu ;
Liu, Hanqiang ;
Tang, Junqi ;
Yang, Ying ;
Jing, Xiaohong ;
Xiao, Qian ;
Wang, Wen ;
Gou, Xingchun ;
Wang, Zongren .
CANCER SCIENCE, 2011, 102 (07) :1287-1292
[8]
Enhancement of arsenic trioxide (AS2O3)-mediated apoptosis using berberine in human neuroblastoma SH-SY5Y cells [J].
Kim, Dae Won ;
Ahan, Song Ho ;
Kim, Tae Young .
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2007, 42 (05) :392-399
[9]
mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma [J].
Kudo, Masatoshi .
DIGESTIVE DISEASES, 2011, 29 (03) :310-315
[10]
Berberine -: antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells [J].
Letasiova, Silvia ;
Jantova, Sona ;
Cipak, L'ubos ;
Muckova, Marta .
CANCER LETTERS, 2006, 239 (02) :254-262